Perjeta 50242-0145-01
Generic: Pertuzumab
- Manufacturer
- Genentech, Inc.
- Dosage Form
- Injection, Solution, Concentrate
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- June 8, 2012
- Listing Expires
- December 31, 2027
- Application
- BLA125409
Need to source Perjeta? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Pertuzumab | 30 mg/mL |
Drug Class
HER2/neu Receptor Antagonist [EPC]HER2/Neu/cerbB2 Antagonists [MoA]HER2/neu Receptor Antagonist [EPC]
Selected Package
50242-0145-01Selected1 VIAL, SINGLE-USE in 1 CARTON (50242-145-01) / 14 mL in 1 VIAL, SINGLE-USE